Your request goes to Bertis Inc.. Follow up with them in Messages on Global Trade Plaza.
Exo-PASS Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package. Exosome RNA Sequencing: PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods. Exosome Lipidomics: We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years. Exosome Proteomics: PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.
Describe what you need once. Suppliers who deal in it see your requirement as a buy lead and can send you offers.
Exo-PASS is an all-in-one quality control solution for exosome therapeutics that provides RNA sequencing, lipidomics, and proteomics analyses as required by Ministry of Food and Drug Safety guidelines. Exosomes are enriched from biofluids and contain proteins, lipids, nucleic acids, and metabolites.
RNA sequencing uses qRT-PCR and novel sequencing methods; lipidomics employs UPLC and Orbitrap Exploris 480 MS with expert analysis; proteomics quantification leverages specialized exosome protein extraction and a dedicated data library. A bioinformatics team reviews and interprets pan-omics data to support research.
The seller has not added a specification yet; ask for the data sheet or test certificate. Ask Bertis Inc. for a firm quote and delivery terms before you order.
Bertis Inc. is a B2B supplier based in South Korea (Republic Of Korea), listed on Global Trade Plaza since October 2026. Use Inquire now or Chat with supplier to ask Bertis Inc. for prices, specifications and documents for Exosome Therapeutics Quality Control Solution.
Ask Bertis Inc. which payment terms they accept for Exosome Therapeutics Quality Control Solution. Agree the payment terms in writing with the supplier before you pay.
Placing an order for Exosome Therapeutics Quality Control Solution with Bertis Inc. is quick and straightforward on Global Trade Plaza, a leading B2B marketplace for global buyers and suppliers. You can:
When purchasing Exosome Therapeutics Quality Control Solution from a B2B marketplace in 2025, focus on the following critical factors:
Comparing prices and communicating directly with Bertis Inc. can help ensure value for money and better sourcing decisions.
Global Trade Plaza is home to B2B buyers, wholesalers, distributors, and importers of Exosome Therapeutics Quality Control Solution across industries and countries. To discover the most active and high-value buyers:
Bertis Inc., a B2B supplier from South Korea (Republic Of Korea), dispatches Exosome Therapeutics Quality Control Solution primarily through the port at South Korea (Republic Of Korea). Packaging types (e.g., bulk, custom, eco-friendly) and estimated pricing may vary based on order volume and destination. To get detailed logistics and pricing information, use Get a quote or Chat with supplier, or Sign Up for direct supplier interaction.